TY - JOUR
T1 - PAK1 kinase is required for CXCL1-induced chemotaxis
AU - Wang, Dingzhi
AU - Sai, Jiging
AU - Carter, Glendora
AU - Sachpatzidis, Aristidis
AU - Lolis, Elias
AU - Richmond, Ann
PY - 2002/6/4
Y1 - 2002/6/4
N2 - The CXC subfamily of chemokines plays an important role in diverse processes, including inflammation, wound healing, growth regulation, angiogenesis, and tumorigenesis. The CXC chemokine CXCL1, or MGSA/GROα, is traditionally considered to be responsible for attracting leukocytes into sites of inflammation. To better understand the molecular mechanisms by which CXCL1 induces CXCR2-mediated chemotaxis, the signal transduction components involved in CXCL1-induced chemotaxis were examined. It is shown here that CXCL1 induces cdc42 and PAK1 activation in CXCR2-expressing HEK293 cells. Activation of the cdc42-PAK1 cascade is required for CXCL1-induced chemotaxis but not for CXCL1-induced intracellular Ca2+ mobilization. Moreover, CXCL1 activation of PAK1 is independent of ERK1/2 activation, a conclusion based on the observations that the inhibition of MEK-ERK activation by expression of dominant negative ERK or by the MEK inhibitor, PD98059, has no effect on CXCL1-induced PAK1 activation or CXCL1-induced chemotaxis.
AB - The CXC subfamily of chemokines plays an important role in diverse processes, including inflammation, wound healing, growth regulation, angiogenesis, and tumorigenesis. The CXC chemokine CXCL1, or MGSA/GROα, is traditionally considered to be responsible for attracting leukocytes into sites of inflammation. To better understand the molecular mechanisms by which CXCL1 induces CXCR2-mediated chemotaxis, the signal transduction components involved in CXCL1-induced chemotaxis were examined. It is shown here that CXCL1 induces cdc42 and PAK1 activation in CXCR2-expressing HEK293 cells. Activation of the cdc42-PAK1 cascade is required for CXCL1-induced chemotaxis but not for CXCL1-induced intracellular Ca2+ mobilization. Moreover, CXCL1 activation of PAK1 is independent of ERK1/2 activation, a conclusion based on the observations that the inhibition of MEK-ERK activation by expression of dominant negative ERK or by the MEK inhibitor, PD98059, has no effect on CXCL1-induced PAK1 activation or CXCL1-induced chemotaxis.
UR - http://www.scopus.com/inward/record.url?scp=0037018934&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037018934&partnerID=8YFLogxK
U2 - 10.1021/bi025902m
DO - 10.1021/bi025902m
M3 - Article
C2 - 12033944
AN - SCOPUS:0037018934
SN - 0006-2960
VL - 41
SP - 7100
EP - 7107
JO - Biochemistry
JF - Biochemistry
IS - 22
ER -